Paper · 22016822
Dissection of the RET/β-catenin interaction in the TPC1 thyroid cancer cell line.
Tartari CJ and 6 others. Am J Cancer Res, 2011. Cited by 19 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Dissection of the RET/β-catenin interaction in the TPC1 thyroid cancer cell line. Papers, record 22016822. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22016822
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17,081,971 | Wnt/beta-catenin signaling in development and disease. | Cell | 2006 | https://conductscience.org/library/papers/17081971 | PubMed |
| 2 | 12,652,644 | RET and NTRK1 proto-oncogenes in human diseases. | J Cell Physiol | 2003 | https://conductscience.org/library/papers/12652644 | PubMed |
| 3 | 10,959,075 | Wnt/beta-catenin signaling. | Cytokine Growth Factor Rev | 2000 | https://conductscience.org/library/papers/10959075 | PubMed |
| 4 | 18,502,340 | Early clinical studies of novel therapies for thyroid cancers. | Endocrinol Metab Clin North Am | 2008 | https://conductscience.org/library/papers/18502340 | PubMed |
| 5 | 19,223,551 | The beta-catenin axis integrates multiple signals downstream from RET/papillary thyroid carcinoma leading to cell proliferation. | Cancer Res | 2009 | https://conductscience.org/library/papers/19223551 | PubMed |
| 6 | 15,713,948 | Wnt/beta-catenin pathway. | Sci STKE | 2005 | https://conductscience.org/library/papers/15713948 | PubMed |
| 7 | 11,713,224 | Identification of a Wnt/beta-catenin signaling pathway in human thyroid cells. | Endocrinology | 2001 | https://conductscience.org/library/papers/11713224 | PubMed |
| 8 | 15,802,236 | Expression, purification, and inhibition of human RET tyrosine kinase. | Protein Expr Purif | 2005 | https://conductscience.org/library/papers/15802236 | PubMed |
| 9 | 19,349,511 | Vandetanib (ZD6474), a dual inhibitor of vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinases: current status and future directions. | Oncologist | 2009 | https://conductscience.org/library/papers/19349511 | PubMed |
| 10 | 19,028,457 | Targeting RET for thyroid cancer therapy. | Biochem Pharmacol | 2009 | https://conductscience.org/library/papers/19028457 | PubMed |
1 to 10 of 26
See all 26 referencesCited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,653,285 | General Assessment of Indole Derivatives and Wnt Pathway as Potential Key Factors Against Various Diseases, with Particular Emphasis on Thyroid Tumors. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653285 | PubMed |
| 41,701,164 | Mutation of rearranged during transfection (RET) is associated with enhanced tumor immunogenicity and favorable outcomes in pan-cancer immunotherapy. | Oncologist | 2026 | https://conductscience.org/library/papers/41701164 | PubMed |
| 39,485,528 | Oncogenic KRAS Mutations Confer a Unique Mechanotransduction Response to Peristalsis in Colorectal Cancer Cells. | Mol Cancer Res | 2025 | https://conductscience.org/library/papers/39485528 | PubMed |
| 35,198,054 | KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt/β-catenin signaling pathway. | Theranostics | 2022 | https://conductscience.org/library/papers/35198054 | PubMed |
| 30,717,910 | Coding Molecular Determinants of Thyroid Cancer Development and Progression. | Endocrinol Metab Clin North Am | 2019 | https://conductscience.org/library/papers/30717910 | PubMed |
| 29,642,644 | Wnt Signaling in Thyroid Homeostasis and Carcinogenesis. | Genes (Basel) | 2018 | https://conductscience.org/library/papers/29642644 | PubMed |
| 29,416,932 | Long noncoding RNA CNALPTC1 promotes cell proliferation and migration of papillary thyroid cancer via sponging miR-30 family. | Am J Cancer Res | 2018 | https://conductscience.org/library/papers/29416932 | PubMed |
| 28,740,507 | MiR-195 Inhibits Tumor Growth and Metastasis in Papillary Thyroid Carcinoma Cell Lines by Targeting CCND1 and FGF2. | Int J Endocrinol | 2017 | https://conductscience.org/library/papers/28740507 | PubMed |
| 28,570,681 | Activated E2F activity induces cell death in papillary thyroid carcinoma K1 cells with enhanced Wnt signaling. | PLoS One | 2017 | https://conductscience.org/library/papers/28570681 | PubMed |
| 27,384,483 | β-catenin signaling is required for RAS-driven thyroid cancer through PI3K activation. | Oncotarget | 2016 | https://conductscience.org/library/papers/27384483 | PubMed |
1 to 10 of 13
See all 13 cited byGenes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CDH1 | 999 | PubTator's text mining | https://conductscience.org/library/genes/999 | NCBI Gene |
| CTNNB1 | 1,499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| RET | 5,979 | PubTator's text mining | https://conductscience.org/library/genes/5979 | NCBI Gene |
| TPCN1 | 53,373 | PubTator's text mining | https://conductscience.org/library/genes/53373 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22016822
GET https://conductscience.org/api/papers/v1/22016822/references?page=2